Robert J Doerksen Selected Research

Robert J Doerksen Research Topics

Disease

6	Malaria 01/2020 - 11/2006
4	Neoplasms (Cancer) 01/2022 - 02/2009
4	Alzheimer Disease (Alzheimer's Disease) 07/2020 - 12/2006
4	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2019 - 09/2014
3	Tuberculosis (Tuberculoses) 11/2023 - 01/2020
3	Pain (Aches) 06/2023 - 10/2018
2	Substance-Related Disorders (Drug Abuse) 01/2024 - 10/2018
2	Nervous System Diseases (Neurological Disorders) 11/2020 - 01/2018
2	Reperfusion Injury 01/2020 - 01/2018
2	Obesity 10/2018 - 02/2012
2	Methemoglobinemia 01/2016 - 02/2011
1	Dengue (Dengue Fever) 01/2024
1	Neuralgia (Stump Neuralgia) 06/2023
1	Peripheral Nervous System Diseases (PNS Diseases) 06/2023
1	Carcinoma (Carcinomatosis) 02/2023
1	Hepatocellular Carcinoma (Hepatoma) 02/2023
1	Urinary Tract Infections (Urinary Tract Infection) 01/2023
1	COVID-19 10/2021
1	Osteoporosis 01/2020
1	Inflammation (Inflammations) 01/2020
1	Multiple Sclerosis 01/2020
1	Mycoses (Diseases, Fungus) 01/2020
1	Parkinson Disease (Parkinson's Disease) 02/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019
1	Schizophrenia (Dementia Praecox) 01/2018
1	Candidiasis (Moniliasis) 08/2016
1	Hemolysis 01/2016
1	Hypertension (High Blood Pressure) 10/2015
1	Body Weight (Weight, Body) 10/2015
1	Hemolytic Anemia 12/2013
1	Infections 01/2010
1	Bipolar Disorder (Manic Depressive Psychosis) 02/2009
1	Stroke (Strokes) 02/2009
1	Amyloid Plaque 12/2006

Drug/Important Bio-Agent (IBA)

3	Cannabinoid Receptors (Cannabinoid Receptor)IBA 06/2023 - 10/2018
3	FlavonoidsIBA 02/2023 - 01/2017
3	Antimalarials (Antimalarial Agents)IBA 01/2016 - 01/2010
2	CannabinoidsIBA 01/2024 - 01/2018
2	EndocannabinoidsIBA 06/2023 - 01/2018
2	Polysaccharides (Glycans)IBA 01/2022 - 10/2021
2	Monoamine Oxidase (MAO)IBA 11/2020 - 02/2019
2	8-aminoquinolineIBA 01/2016 - 02/2011
2	Primaquine FDA Link 01/2016 - 12/2013
2	Glycogen Synthase (Synthase I)IBA 02/2009 - 12/2006
1	VaccinesIBA 01/2024
1	1,2,4-triazoleIBA 11/2023
1	anandamide (arachidonylethanolamide)IBA 06/2023
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 02/2023
1	prenylIBA 02/2023
1	LectinsIBA 01/2023
1	NucleosidesIBA 01/2022
1	UDP-N-acetylglucosamine-peptide beta-N-acetylglucosaminyltransferaseIBA 01/2022
1	alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferaseIBA 01/2022
1	Cholinergic Agents (Cholinergics)IBA 07/2020
1	ferulic acid (sodium ferulate)IBA 07/2020
1	EchinocandinsIBA 01/2020
1	acacetinIBA 02/2019
1	AlkaloidsIBA 01/2019
1	PyrroloiminoquinonesIBA 01/2019
1	virodhamineIBA 01/2018
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2017
1	CyclodextrinsIBA 08/2016
1	Clotrimazole (Lotrimin)FDA LinkGeneric 08/2016
1	MethemoglobinIBA 01/2016
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2016
1	Antihypertensive Agents (Antihypertensives)IBA 10/2015
1	Peptides (Polypeptides)IBA 10/2015
1	Dihydrotachysterol (AT 10)IBA 10/2015
1	Synthetic DrugsIBA 10/2015
1	tau Proteins (tau Protein)IBA 11/2014
1	tau-protein kinaseIBA 09/2014
1	Phosphotransferases (Kinase)IBA 09/2014
1	Nitric Oxide Synthase (NO Synthase)IBA 02/2011
1	Chloroquine (Aralen)FDA LinkGeneric 01/2010
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 02/2009

Therapy/Procedure

6	Therapeutics 06/2023 - 11/2006
1	Drug Therapy (Chemotherapy) 01/2022
1	Oral Administration 10/2015